COMPLEMENT COMPONENT C4 - ANVISA Registration 81357320059

Access comprehensive regulatory information for COMPLEMENT COMPONENT C4 in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 81357320059 and manufactured by THE BINDING SITE GROUP LTD. The registration is held by THE BINDING SITE BRASIL COMERCIO DE PRODUTOS PARA LABORATORIO LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including BIOSYSTEMS S.A., THE BINDING SITE GROUP LTD, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
81357320059
Registration Details
ANVISA Registration Number: 81357320059
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

Human Complement C2 NL Bindarid Kit
Risk Class II

Registration Details

81357320059

25351258816201817

23119193000108

Company Information

United Kingdom
PT: REINO UNIDO

Dates and Status

May 21, 2018

VIGENTE

09/18/2025 19:00:01